Transparency Market Research published new market report"Diagnostic Testing of STDs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 – 2019". Sexually Transmitted Diseases (STDs) are diseases that spread primarily through person-to-person sexual contact. Varied testing technologies used for the identification and analysis of the STD contracted comprise the definition of ‘diagnostic testing of STDs’. The location where diagnostic tests are delivered i.e. in the laboratories or at the point-of-care (POC) also comprises the definition of ‘diagnostic testing of STDs’. This report studies the market for diagnostic testing of STDs from the point of view of the testing services offered in the market in terms of testing volume and value. The overall diagnostic testing of STDs market is classified into Chlamydia testing, Gonorrhea testing, P&S Syphilis testing, HPV testing, HSV testing, HIV testing and Chancroid testing. The diagnostic testing of STDs market is also studied from the aspect of location or point of delivery of testing i.e. at laboratories or at the POC. The market size and forecast for the period 2013 – 2019, in terms of USD million, considering 2012 as the base year has been provided for each segment in the report. The compound annual growth rate (CAGR) for each segment has been provided for the forecast period from 2013 – 2019. Browse the report With Full TOC at http://www.transparencymarketresearch.com/diagnostic-testing-stds.html

1. REPORT DESCRIPTION
Diagnostic Testing of STDs Market is Expected to Reach USD 108.5 Billion Globally
in 2019: Transparency Market Research
Transparency Market Research published new market report “Diagnostic Testing of STDs
Market (Laboratory Testing, Point-Of-Care Testing, Laboratory Equipment and
Supplies) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,
2013 - 2019" the global Diagnostic Testing of STDs market was valued at USD 65.9 billion
in 2012 and is expected to grow at a CAGR of 8.1% from 2013 to 2019, to reach an
estimated value of USD 108.5 billion in 2019.
Sexually Transmitted Diseases (STDs) spread primarily through person-to-person sexual
contacts. STDs result in high morbidity in adults and also result in complications such as
infertility in both men and women, ectopic pregnancy, cervical cancer in women and
congenital mortality and other infections and complications. STDs are a health issue that
majorly affect populace aged 15 - 44 years and results in ~500 million new infections or
cases per year globally. Undiagnosed (that often results in untreated cases) STDs can have
critical implications for reproductive, maternal and newborn health. WHO has highlighted
the need and prioritizing control of STDs. In May 2006, the World Health Assembly endorsed
a global strategy for the prevention and control of STDs and identified action-points of
Transparency Market Research
Diagnostic Testing of STDs
Market - Global Industry
Analysis, Size, Share,
Growth, Trends and
Forecast, 2013 – 2019
Single User License: US $ 4795
Multi User License: US $ 7795
Corporate User License: US $ 10795
Buy Now
Request Sample
Published Date: OCT 2013
90 Pages Report

2. scale-up of effective services of STDs case management and counseling via: Screening and
Diagnostic Testing and Treatment. Timely diagnosis of STDs is thus imperative for
prevention of transmission, control and reducing the risk of incurable and fatal STD
infections.
STDs are caused by bacteria, viruses and parasites. Some of the most prevalent STDs that
are studied are: Chlamydia, Gonorrhea, P&S Syphilis, Chancroid, AIDS (causative agent -
HIV), Genital Herpes (causative agent - Herpes Simplex Virus (HSV)), Genital Warts,
Cervical Cancer, Anal Cancer, Vulval/Vaginal Cancer, Penal Cancer, (few types) of Oral and
Throat Cancers (causative agent - Human Papilloma Virus (HPV)). The market size of
diagnostic testing of above-mentioned STDs thus refers to the testing volume by each STD
type and the value of the testing services rendered in USD million.
Globally, the HPV testing is a high growth market segment that is expected to grow at very
high CAGR of over 70% during the forecast period till 2019. HPV is of two types - Low-risk
HPV manifest as warts and High-risk HPV that cause varied forms of cancer. The prevalence
and incidence rates and number of cases for Low-risk HPV infections depends on the first
presentation of warts by the patients and Low-risk HPV diagnostic tests cannot be of
'screening' nature. For High-risk HPV types, HPV 'co-testing' is done by varied laboratory
testing methods and additionally, pap smear tests are also carried out to detect High-risk
HPV types in cancer cases. Thus the HPV testing volume is a cumulative result of factors
and thus due to these reasons, we estimate that HPV testing volume is expected to grow at
a very high CAGR till 2019.
Currently, in terms of geography, North America and Europe have a higher market share in
terms of testing volume of the most prevalent STDs namely Chlamydia, Gonorrhea and P&S
Syphilis. Many countries in Asia-Pacific and the entire RoW region has garnered a higher
market share in terms of testing volume of primarily viral STDs such as HIV, HSV and
Chancroid.
The Global Diagnostic Testing of STDs market is segmented as follows:
Diagnostic Testing of STDs Market, by STD type
 Chlamydia testing
 Gonorrhea testing
 P&S Syphilis testing
 Human Papilloma Virus (HPV) testing
 Herpes Simplex Virus (HSV) testing
 Human Immunodeficiency Virus (HIV) testing

3.  Chancroid testing
Diagnostic Testing of STDs Market, by Location
 Laboratory Testing
 Point-Of-Care (POC) Testing
Diagnostic Testing of STDs Market, by Geography
 North America
 Europe
 Asia-Pacific
 Rest of the World (RoW)
TABLE OF CONTENTS
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 Assumptions
Chapter 2 Executive Summary
Chapter 3 Introduction: Diagnostic Testing of STDs
3.1 Definition - Diagnostic Testing of STDs
3.2 Significance of STDs, STDs control and prevention
3.3 Types of Diagnostic Tests of STDs
Chapter 4 Global Diagnostic Testing of STDs Market Overview
4.1 Overview
4.2 Drivers

4. 4.2.1 Increasing prevalence and incidence rates of STDs
4.2.2 National Screening Programs implemented
4.2.3 Favourable reimbursement for STDs testing
4.3 Restraints
4.3.1 Stigma associated with voluntary/CICT STD testing
4.3.2 Large proportion of STD infected patients in out-of-reach geographic areas
4.3.3 Stringent regulatory compliance requirements for market participants
4.4 Opportunities
4.4.1 National screening programs across regions - an opportunity for laboratory tests
and POC tests / technologies providers
4.4.2 Declining visits to specialized STD and GUM clinics - an opportunity for public /
private labs
4.4.3 RoW and Asia-Pacific markets - niche opportunity for POC tests/ technologies
providers
4.5 Market Attractiveness Analysis: Global Diagnostic Testing of STDs Market, by Geography
Browse the full report with complete TOC
at http://www.transparencymarketresearch.com/diagnostic-testing-stds.html.
Chapter 5 Global Diagnostic Testing of STDs Market, by STD Type, 2013 - 2019
(USD Million)
5.1 Chlamydia testing
5.1.1 Global Chlamydia Diagnostic Testing Market, Volume (in Millions)
5.1.2 Global Chlamydia Diagnostic Testing Market, Value (USD Million)
5.2 Gonorrhea testing
5.2.1 Global Gonorrhea Diagnostic Testing Market, Volume (in Millions)
5.2.2 Global Gonorrhea Diagnostic Testing Market, Value (USD Million)
5.3 P&S Syphilis testing

5. 5.3.1 Global P&S Syphilis Diagnostic Testing Market, Volume (in Millions)
5.3.2 Global P&S Syphilis Diagnostic Testing Market, Value (USD Million)
5.4 HPV testing
5.4.1 Global HPV Diagnostic Testing Market, Volume (in Millions)
5.4.2 Global HPV Diagnostic Testing Market, Value (USD Million)
5.5 HSV testing
5.5.1 Global HSV Diagnostic Testing Market, Volume (in Millions)
5.5.2 Global HSV Diagnostic Testing Market, Value (USD Million)
5.6 HIV testing
5.6.1 Global HIV Diagnostic Testing Market, Volume (in Millions)
5.6.2 Global HIV Diagnostic Testing Market, Value (USD Million)
5.7 Chancroid testing
5.7.1 Global Chancroid Diagnostic Testing Market, Volume (in Millions)
5.7.2 Global Chancroid Diagnostic Testing Market, Value (USD Million)
5.8 Laboratory Equipment and Supplies Market
Related & Recently Published Reports by Transparency Market Research
 Clinical Laboratory Services
Market: http://www.transparencymarketresearch.com/clinical-laboratory-
services-market.html
 Home Automation
Market: http://www.transparencymarketresearch.com/home-automation-
market.html
 Medical Tourism
Market: http://www.transparencymarketresearch.com/medical-
tourism.html
 Anesthesia and Respiratory Devices
Market:http://www.transparencymarketresearch.com/anesthesia-
respiratory-devices.html

6.  Maleic Anhydride
Market: http://www.transparencymarketresearch.com/maleic-anhydride-
market.html
Chapter 6 Global Diagnostic Testing of STDs Market, by Location, 2013 - 2019
(USD Million)
6.1 Laboratory Testing
6.2 POC Testing
Chapter 7 Global Diagnostic Testing of STDs Market, by Geography, 2013 - 2019
(USD Million)
7.1 Introduction
7.1.1 Global Diagnostic Testing of STDs Market, by Geography, 2013 - 2019 (USD
Million)
7.2 Chlamydia Diagnostic Testing: Regional (North America, Europe, Asia-Pacific & RoW)
Market Size, 2013 and 2019 (USD Million)
7.3 Gonorrhea Diagnostic Testing: Regional (North America, Europe, Asia-Pacific & RoW)
Market Size, 2013 and 2019 (USD Million)
7.4 P&S Syphilis Diagnostic Testing: Regional (North America, Europe, Asia-Pacific & RoW)
Market Size, 2013 and 2019 (USD Million)
7.5 HPV Diagnostic Testing: Regional (North America, Europe, Asia-Pacific & RoW) Market
Size, 2013 and 2019 (USD Million)
7.6 HSV Diagnostic Testing: Regional (North America, Europe, Asia-Pacific & RoW) Market
Size, 2013 and 2019 (USD Million)
7.7 HIV Diagnostic Testing: Regional (North America, Europe, Asia-Pacific & RoW) Market
Size, 2013 and 2019 (USD Million)
7.8 Chancroid Diagnostic Testing : Regional (North America, Europe, Asia-Pacific & RoW)
Market Size, 2013 and 2019 (USD Million)
Chapter 8 Recommendations
8.1 Gain accreditation to ensure qualification to participate in National Screening Programs
across regions

7. 8.2 Investment In Laboratory Infrastructure In Developed Regions
8.3 Investing in Asia-Pacific and RoW markets
Browse the full report with complete TOC
at http://www.transparencymarketresearch.com/diagnostic-testing-stds.html.
Chapter 9 Company Profiles
9.1 Roche Holdings AG
9.1.1 Company Overview
9.1.2 Financial Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies
9.2 Alere, Inc.
9.2.1 Company Overview
9.2.2 Financial Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.3 Becton Dickinson & Company
9.3.1 Company Overview
9.3.2 Financial Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.3.5 Recent Developments
9.4 bioMerieux
9.4.1 Company Overview
9.4.2 Financial Overview
9.4.3 Product Portfolio

8. 9.4.4 Business Strategies
9.4.5 Recent Developments
9.5 Danaher Corporation (Beckman Coulter)
9.5.1 Company Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.6 Hologic, Inc. (Gen-Probe)
9.6.1 Company Overview
9.6.2 Financial Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies
About Us:
Transparency Market Research is a market intelligence company providing global business
information reports and services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants,
who use proprietary data sources and various tools and techniques to gather, and analyze
information. Our business offerings represent the latest and the most reliable information
indispensable for businesses to sustain a competitive edge.
Contact:
Transparency Market Research
90 State Street, Suite 700, Albany
NY – 12207, United States
Tel: +1-518-618-1030, USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/